中国经济网北京9月25日讯 富瀚微（300613.SZ）昨日发布关于控股股东、实际控制人及其一致行 动人持股比例变动触及1%整数倍的公告。 本次权益变动系因富瀚微股东杰智控股有限公司（以下简称"杰智控股"）减持股份及公司总股本增 加，导致公司控股股东、实际控制人杨小奇先生及其一致行动人杰智控股有限公司、陈春梅女士、龚传 军先生合计持股比例累计变动触及1%整数倍。本次权益变动不触及要约收购，不会导致公司控股股东 及实际控制人发生变化，不会影响公司的治理结构和持续经营。 富瀚微8月28日披露了关于公司筹划境外发行股份（H股）并在香港联合交易所有限公司上市的提 示性公告。 为深化公司全球化战略布局，加快海外业务发展，提升公司国际化品牌形象，同时打造多元化资本 运作平台，进一步增强公司资本实力，助力公司高质量发展，公司拟筹划境外发行股份（H股）并申请 在香港联交所挂牌上市（以下简称"本次发行H股并上市"）的相关工作，正在计划与相关中介机构就本 次发行H股并上市的具体推进工作进行商讨，关于本次发行H股并上市的细节尚未确定。 待确定具体方案后，本次发行H股并上市尚需提交公司董事会和股东会审议，并需取得中国证券监 督管理委 ...

Core Viewpoint - The company, Shanjin International Gold Co., Ltd., has submitted an application for the issuance of overseas listed shares (H-shares) and listing on the Hong Kong Stock Exchange on September 24, 2025, which is a significant step towards expanding its capital base and attracting foreign investment [1][2]. Group 1 - The application for the H-share issuance has been filed with the Hong Kong Stock Exchange and is in compliance with the requirements set by the Hong Kong Securities and Futures Commission [1]. - The subscription for this issuance is limited to qualified overseas investors and domestic qualified investors who are authorized to conduct overseas securities investments under Chinese laws [1]. - The company will not publish the application materials on domestic stock exchange websites or media, but provides links for domestic investors to access the information on the Hong Kong Stock Exchange website [1]. Group 2 - The issuance is subject to approval and/or registration by relevant government and regulatory bodies, including the China Securities Regulatory Commission, the Hong Kong Securities and Futures Commission, and the Hong Kong Stock Exchange, indicating a level of uncertainty regarding the approval process [2]. - The company commits to timely information disclosure in accordance with relevant laws and regulations based on the progress of the issuance [2].

Group 1 - Company plans to issue H-shares and list on the Hong Kong Stock Exchange to optimize overseas business layout and diversify financing channels [1] - The H-share issuance is subject to approval from the board, shareholders, and regulatory bodies, with significant uncertainty regarding its implementation [1] - For the first half of 2025, the company reported revenue of approximately 8.494 billion yuan, a year-on-year increase of about 56.59%, and a net profit of approximately 1.683 billion yuan, up about 47.50% [1] Group 2 - The PCB business generated revenue of approximately 8.152 billion yuan, reflecting a year-on-year growth of about 57.20%, although the gross margin decreased by approximately 1.49 percentage points due to increased equity incentive costs and losses from the Thailand plant [1] - Senior management member Li Minggui plans to reduce his shareholding by up to 160,400 shares, representing about 0.0083% of the total share capital, within a three-month period starting from September 23, 2025 [2] - The company reported a negative cash flow from investment activities of approximately 1.363 billion yuan for the first half of 2025, a decline of 31.85% compared to the same period last year [3] Group 3 - Negative cash flow from investment activities for 2023 and 2024 was reported at approximately 1.870 billion yuan and 3.035 billion yuan, respectively [4]

Core Viewpoint - Chengdu Olin Biological Technology Co., Ltd. is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy, increase its global visibility, and optimize its capital structure [1][2]. Group 1 - The company is currently discussing the details of the H-share listing with relevant intermediaries, and specific details have not yet been finalized [2]. - The H-share listing process will require approval from the company's board and shareholders, as well as regulatory approvals from the China Securities Regulatory Commission, the Hong Kong Stock Exchange, and the Securities and Futures Commission of Hong Kong [2]. - The company will fulfill its information disclosure obligations in accordance with relevant laws and regulations as the H-share listing progresses [2].

登录新浪财经APP 搜索【信披】查看更多考评等级 根据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易所股票上市规则》《境内企 业境外发行证券和上市管理试行办法》《香港联合交易所有限公司证券上市规则》等相关法律法规的要 求，待确定具体方案后，本次H股发行上市尚需提交公司董事会和股东会审议，并需取得中国证券监督 管理委员会、香港联交所和香港证券及期货事务监察委员会等相关政府机构、监管机构备案、批准或核 准。本次H股发行上市能否通过审议、备案和审核程序并最终实施具有较大不确定性。 公司将依据相关法律法规的要求，根据本次H股发行上市的后续进展情况及时履行信息披露义务，切实 保障公司及全体股东的合法权益。敬请广大投资者关注公司后续公告，注意投资风险。 特此公告。 苏州东山精密制造股份有限公司董事会 2025年9月23日 证券代码：002384 证券简称：东山精密公告编号：2025-065 苏州东山精密制造股份有限公司 关于筹划发行 H 股股票并在香港联合交易所有限公司上市相关事项的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 苏州东山精密制 ...

根据备案通知书，南华期货拟发行不超过约1.55亿股股境外上市普通股并在香港联合交易所上市。 来源：瑞恩资本 2025年9月19日，中国证监会国际合作司发布关于南华期货股份有限公司(以下简称南华期货)境外发行 上市备案通知书(国合函[2025]1618号)。 南华期货招股书链接： https://www1.hkexnews.hk/app/sehk/2025/107301/documents/sehk25041702069_c.pdf 南华期货(603093.SH)，于2019年8月30日在A股上市，为中国首家在A股上市的期货公司，截至周一 (2025年9月22日)收市，总市值约人民币131亿元。 南华期货，于2025年4月17日在港交所递交招股书，中信证券独家保荐。 南华期货，成立于1996年，作为一家综合性的全球金融服务平台，产品服务包括中国境内期货经纪、中 国境内风险管理服务、中国境内财富管理以及境外金融服务，涵盖了期货及衍生品的整个价值链。根据 弗若斯特沙利文报告，在中国：按2023年总收入计，南华期货在所有期货公司中排名第8，在所有非金 融机构相关期货公司中排名第1；按2023年期货经纪佣金收入计，其在 ...

Group 1 - The company plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy and brand image [2][3] - The board meeting was held on September 22, 2025, with all 8 directors present, and the resolutions were passed unanimously [2][4] - The issuance of H-shares is part of the company's strategy to improve its core competitiveness and expand internationally [2][3] Group 2 - The H-shares will be issued in the form of ordinary shares with a nominal value of RMB 1.00 per share [7] - The issuance will target global investors, including public investors in Hong Kong and qualified domestic institutional investors [12] - The initial issuance scale will not be less than 10% of the total share capital after the issuance, with an option for an overallotment of up to 15% [16] Group 3 - The company will determine the final issuance price based on market conditions and investor demand [18] - The issuance will be conducted through public offerings in Hong Kong and international placements [14] - The company will incur various costs related to the issuance, including underwriting fees and legal expenses, which will be negotiated with intermediaries [26] Group 4 - The company will transition to a foreign-funded joint-stock company upon successful issuance and listing of H-shares [31] - The validity period for the resolutions related to the issuance is set for 24 months from the date of shareholder approval [32] - The proceeds from the issuance will be used for R&D, global expansion, and general corporate purposes [33] Group 5 - The company will apply for registration as a non-Hong Kong company in accordance with relevant regulations [34] - The company will revise its articles of association and governance rules to align with the requirements of the H-share issuance [35][38] - The board will appoint various intermediaries, including auditors and legal advisors, for the issuance process [28][54]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来自深圳的A股上市公司佰维存储(688525.SH)发布公告称，为深化公司全球化战略布局，提升公司国际 化品牌形象，并进一步提升公司核心竞争力，公司拟发行境外上市股份(H股)股票并申请在香港联合交 易所有限公司主板挂牌上市。根据相关法律法规的要求，公司本次发行上市符合中国境内法律、法规和 规范性文件的要求和条件，同意在经过董事会和股东会审议后向中国证券监督管理委员会、香港联交所 等有关监管机构提出本次境外发行股票并上市的申请。 佰维存储表示，截至目前，公司正积极与相关中介机构就本次发行上市的相关工作进行商讨，除本次董 事会审议通过的相关议案外，其他关于本次发行上市的具体细节尚未最终确定。 佰维存储同时公告，董事会同意公司聘任天健国际会计师事务所有限公司为公司香港上市的审计机构。 佰维存储，主要从事半导体存储器的研发设计、封装测试、生产和销售，主要产品及服务为半导体存储 器和先进封测服务，致力于成为全球一流的存储与先进封测厂商。公司紧紧围绕半导体存储器产业链， 构筑了研发封测一体化的经营模式，布局存储解决方案研发、主控芯片设计、存储器封测 ...

格隆汇9月22日丨佰维存储(688525.SH)公布，为深化公司全球化战略布局，提升公司国际化品牌形象， 并进一步提升公司核心竞争力，公司拟发行境外上市股份(H股)股票并申请在香港联合交易所有限公司 (称"香港联交所")主板挂牌上市。 ...

Core Viewpoint - Nanhua Futures is applying for the issuance of overseas listed shares (H-shares) and plans to list on the main board of the Hong Kong Stock Exchange [1] Group 1: Company Actions - The company has received a notice from the China Securities Regulatory Commission regarding the filing for overseas issuance and listing [1] - The filing notice includes plans to issue no more than 124 million overseas listed ordinary shares [1] - The company must complete the overseas issuance and listing within 12 months, or it will need to update its filing materials [1] Group 2: Regulatory Information - The filing notice only confirms the filing information and does not guarantee investment value or returns [1]